Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02509377 · ClinicalTrials.gov registry record · NA
Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0
A NA study, sponsored by St. Louis University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02509377: Clinical Trial NA study, sponsored by St. Louis University.
NCT02509377 is a NA study that was terminated before completion, run by St. Louis University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02509377, a NA study, was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for obesity. Investigators plan to expand one exclusion criteria for open fetal repair surgery. Currently, an exclusion factor is a maternal BMI of 35.0 and greater.Investigators will maintain all other inclusion and exclusion criteria (including excluding for hypertension and diabetes) with the exception of expanding the BMI to include mothers with a BMI of 35.0 to 40.0. Co-morbidities of the research group will be compared to the comorbidities of the mothers published in the MOMS trial.
Primary Outcome
Measure the co-morbidity of mothers with a BMI of 35.0 to 40.0. Compare to published data in the MOMS trial.
Interventions
- PROCEDURE Open Fetal Repair of Myelomeningocele
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-05 |
| Phase | NA |
Why NCT02509377 stopped before completion
NCT02509377 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Open Fetal Repair of Myelomeningocele is the first listed.
NCT02509377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02509377 about?
NCT02509377 is a clinical study titled "Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0". Inclusion and exclusion criteria for fetal repair of MMC was established by the Management of Myelomeningocele Study (MOMS Trial) and these criteria are the standard of care throughout the United States. These criteria state exclusion for hypertension and diabetes which are known co-morbidities for ...
What is the current status of trial NCT02509377?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2015-07. Estimated completion is 2017-05.
What interventions are being tested in trial NCT02509377?
The interventions under investigation include: Open Fetal Repair of Myelomeningocele (PROCEDURE).
Who is sponsoring clinical trial NCT02509377?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02509377's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia